2021 News

CHGPM Announcement

We are excited to announce that, effective June 1, 2021, Muhammed Murtaza, MBBS, PhD has accepted the position of Associate Director for the Center for Human Genomics and Precision Medicine. As Associate Director, Dr. Murtaza will chair the Center’s internal advisory committee, oversee Center informatics infrastructure, and maintain Center relationships with stakeholders and partners.  He also will work together with Center Director Dr. Stephen Meyn on strategic planning and initiatives, as well as faculty recruiting and educational activities.

Dr. Murtaza is an Associate Professor in the Department of Surgery’s Division of Surgical Oncology.  His research group is based in the Center for Human Genomics Medicine where he leads the Center’s Novel Diagnostics Program.  Dr. Murtaza’s research focuses on developing novel computational and molecular methods and applications for minimally invasive cancer genomics and diagnostics, including the use of circulating tumor DNR (ctDNA) analyses for cell-free genomics-based diagnostic tests.

Dr. Murtaza earned a Bachelor of Medicine and Bachelor of Surgery (equivalent to U.S. MD) at Aga Khan University Medical College in Karachi, Pakistan, and a PhD in Medical Science from the Cancer Research UK Cambridge Institute at the University of Cambridge. Before he was recruited to UW-Madison in 2020 he was an Assistant Professor of Medicine at Mayo Clinic in Scottsdale, Arizona, and faculty member and co-director of the Center for Noninvasive Diagnostics in the Translational Genomics Research Institute in Phoenix.

The CHGPM is an interdisciplinary research center whose mission includes growing and nurturing the University’s human genomics and precision medicine community; catalyzing research, clinical and educational activities; and sharing the benefits of precision medicine with all Wisconsinites.

Dr. Murtaza can be contacted at murtaza@surgery.wisc.edu

STUDY FINDS ANALYZING DNA IN URINE COULD HELP DETECT CANCER

A study published this week in Science Translational Medicine describes how urinalysis could potentially be used to detect some forms of cancer. This study was led by Dr. Muhammed Murtaza, associate professor of surgery and Center for Human Genomics and Precision Medicine occupant. The work was performed while Murtaza was at the Translational Genomics Research Institute in Arizona.

See the study here:

https://stm.sciencemag.org/content/13/581/eaaz3088